Since 2010 VivoSense has been helping clinical researchers analyze and interpret wearable sensor data to improve patient research and care. Following our $25M Series A Financing in March 2022, we are on the fast track to adding passionate and motivated team members!
“My work as a scientist building trusted digital clinical measures is incredibly rewarding as I can see clearly how they have the potential to improve clinical research and healthcare. I’m lucky that I get to work with a team of phenomenally talented, dedicated, and motivated people to make it happen.”
~ Jen Blankenship, PhD, VivoSense Clinical Scientist